BEYFORTUS: payments to doctors
Payments that named BEYFORTUS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.2M
- Providers
- 21,503
- Transactions
- 38,204
- Average per transaction
- $58
The per-transaction average — $58 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 21,503 providers the average total is $103, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi Pasteur Inc. | $2,215,268 | 99.7% |
| Sanofi | $7,025 | 0.3% |
| Sanofi-aventis U.S. LLC | $213 | 0.0% |